Jammu, India

Rajesh Kumar Thaper

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Haryana, IN (1998 - 2003)
  • Hidersbad, IN (2003)
  • Banjara Hills, IN (2013)
  • Jammu, IN (2013 - 2016)

Company Filing History:


Years Active: 1998-2016

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Rajesh Kumar Thaper: A Trailblazing Innovator in the Pharmaceutical Industry

Introduction:

Throughout his illustrious career, Rajesh Kumar Thaper has consistently demonstrated a remarkable ability to develop groundbreaking solutions to complex problems. With his inventive mindset and technical expertise, Thaper has created a significant impact in the pharmaceutical field. In this article, we delve into Thaper's career highlights, latest patents, collaborations, and the recognition he has earned in the industry.

Latest Patents:

Thaper's latest patents include two significant inventions:

1. Process for the preparation of dasatinib and its intermediates: This patent encompasses an innovative process for the synthesis of dasatinib and its intermediates. Dasatinib is a highly effective medication used in the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Thaper's method offers a more efficient and cost-effective route to produce this life-saving drug.

2. Process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate: The second patent highlights Thaper's contribution to the synthesis of crystalline Form I of methanesulfonate salt of dabigatran etexilate. This process eliminates the need for isolating the dabigatran etexilate intermediate, leading to improved efficiency in the production of this anticoagulant medication.

Career Highlights:

Thaper's career is adorned with several notable achievements, showcasing his talent and expertise. He has secured a total of 17 patents throughout his professional journey, a testament to his commitment to innovation. Thaper's inventions have not only revolutionized the field of pharmaceuticals but have also positively impacted patient care and treatment options.

Collaborations:

Thaper has had the privilege of working with esteemed organizations, including Ranbaxy Laboratories, Inc. and Sun Pharmaceutical Industries Limited. These collaborations have allowed him to leverage his skills and knowledge alongside other industry leaders, contributing to a collaborative culture of innovation.

Conclusion:

Rajesh Kumar Thaper's exceptional career is a shining example of the revolutionary impact one innovator can make within the pharmaceutical industry. With a multitude of patents, including the recent groundbreaking processes for dasatinib and dabigatran etexilate, Thaper has elevated the standard of drug synthesis and treatment options. Through his collaborations and contributions, Thaper continues to leave an indelible mark on the field. To explore Thaper's illustrious career in detail, please visit our website idiyas.com, where you'll find comprehensive information about his patents, inventions, and professional milestones.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…